Gynecologic malignancies in women younger than 40 years of age: A SEER database review.

Princy Shah,Kashyap Kela,Upendra P. Hegde
DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e17605
IF: 45.3
2024-06-01
Journal of Clinical Oncology
Abstract:e17605 Background: Gynecologic malignancies are one of the most common types of cancers in women, but their Epidemiology in young women is not widely known. Here we present the demographics and comparison between uterine, cervical, ovarian, vagina, and vulvar cancers in women under age 40 years based on the Surveillance, Epidemiology, and End Results (SEER) database analysis. Methods: Information was collected from the SEER database November 2022 with the data from years 2000-2020 containing 17 registries. Site recode ICD O-3/WHO 2008 Female Genital system was applied and Primary sites labeled 51.8 to 56.9 were selected. Patient population with only one primary site of Malignancy was included, and the cases with No specific sites were excluded. Age recode 0-39 years was applied. Variables of Age group, Race, Ethnicity, Median household income, Areas of residence & survival months were selected. Data was extracted for a total of 34056 patients. The Chi-square test was used for statistical analysis. P value <0.05 was considered significant. Results: The most common site of Gynecologic cancer was Cervix (50.4%) followed by Uterus (24.2%) and Ovary (23%). Vulvar(1.9%) and Vaginal (0.6%) cancers were the rarest. Squamous cell carcinoma was the most common histology for cervical (42.9%), vaginal (26%), Vulvar (51%) cancer versus Endometrioid histology for uterine (69.2%) and teratoma for ovarian (12.5%) cancer. The most common age group affected was 34-39 (44.1%) with decreasing frequency with younger age. 30.5% of participants belonged to 30-34 years of age. A total of 14 cases were noted in patients less than 1 year of age with most cases of vaginal and ovarian cancer. Non-Hispanic whites had the highest occurrence (48.8%) followed by Hispanics (28.4%), Blacks (10.7 %), Asian/Pacific Islanders (9.7%), and Alaskan/American natives (1.2%). Compared to high household income, patients with lower household income of <75,000 US dollars (USD) comprised of 61.9% of total Gynecologic malignancies. 89% of the total cases were observed in Metropolitan cities versus non-metropolitan areas. 5-year survival rate was observed at 57% overall. Vulvar cancer had the highest survival rate of 60.1% followed by Uterine (57.9%), Vaginal (57.1%), Cervix (56.1%), and Ovarian (56%) cancer. Conclusions: Early onset Gynecologic malignancies are more common in non-Hispanic whites, in Median Household income <75,000 USD, and in Metropolitan cities. Incidence increases with age. Vulvar cancer has the best 5 years survival and Ovarian has the worst one. Cervical cancer (50.4% of total cases) screening should be continued as per current guidelines. However, with Uterine and Ovarian cancers collectively contributing to close to half the Gynecologic malignancies, Practitioners should maintain high clinical suspicion to have appropriate individualized workups based on Risk Factors for early Diagnosis and Management of these cancers in this age group.
oncology
What problem does this paper attempt to address?